We found that the strain Aspergillus fumigatus var. fumigatus RK95-113 produced a new angiogenesis inhibitor, RK-95113. Spectroscopic analyses identified the structure of RK-95113 as a new fumagillin-related small molecule. RK-95113 preferentially inhibited the growth of human umbilical vein endothelial cells (HUVECs) rather than that of human normal fibroblasts in cell proliferation assays and blocked endothlial cell migration induced by vascular endothelial growth factor (VEGF).
angiogenesis inhibitors, as several small molecules with antiangiogenic activity are not clinically useful for toxicity and efficacy [1ϳ5] .
In this regard, we have commenced a screening program to identify and develop new angiogenesis inhibitors derived from microbial metabolites. Recently, we reported the identification of novel angiogenesis inhibitors, epoxyquinols A and B, epoxytwinol A, azaspirene, and RK-805, isolated from fungal metabolites [6ϳ10] . In the course of our phenotypic screening for angiogenesis inhibitors, RK-95113 ( Fig. 1a) was discovered from the fermentation broth of Aspergillus fumigatus var. fumigatus RK95-113 (JCM 12527, FERM P-19233). The strain was isolated from soil collected in Wako, Saitama, Japan, and identified according to the methods of Klich and Pitt [11, 12] as well as by comparison with the Aspergillus Reference Cultures (http://www.cbs.knaw.nl/ICPA/) maintained in the Japan Collection of Microorganisms (JCM; http://www.jcm.riken. jp/JCM/aspref.html). The strain was inoculated into two 30-liter jar fermenters, each containing 15 liters of the culture medium, as previously described [10] . Further work on the culture broth led to the isolation of RK-95113 [13] .
The molecular formula of RK-95113 was determined to be C 24 (Fig.  1b ), H-11 through H-13 and H-2Ј through H-8Ј, indicated the presence of an alkenyl moiety including a terminal methyl proton. Also, long-range couplings from H-15 to C-4, C-10, and C-11; from H-16 and H-17 to C-13 and C-14; and from H-2Ј to carbonyl carbon at C-1Ј were observed in the PFG-HMBC experiment (Fig. 1b) . Thus, the linkages from C-10 to C-17 and from C-1Ј to C-8Ј were established. The cyclohexanol skeleton was confirmed by 1 H-1 H corrleations in PFG-DQFCOSY: H-4 through H-8, as well as by 1 H- 13 C correlations in the PFG-HMBC spectra: the strong two-and three-bond 1 H- 13 C correlations from H-18 of the methoxy proton signal to C-5 and from the proton at H-6 to the carbonyl carbon at the C-1Ј position. The exocyclic epoxide ring on cyclohexanol was confirmed by the chemical shifts, coupling constants, and two strong correlations from H-2, H-4, and H-8 to C-3 in the PFG-HMBC experiment. Thus, the planar structure of RK-95113 with the fumagillol nucleus and alkenyl moiety was established. The relative stereochemistry of RK-95113 was elucidated by NOE experiments (Fig. 1c) 2.55) were observed, indicating that H-4 and H-5 were both axial and H-6 was equatorial. The geometry of the three conjugated double bonds was determined as all-E on the basis of the coupling constants (J 2Ј,3Ј ϭ15.2 Hz, J 4Ј,5Ј ϭ14.2 Hz, and J 6Ј,7Ј ϭ14.4 Hz) and the NOE correlations between H-2Ј and H-4Ј, H-3Ј and H-5Ј, H-4Ј and H-6Ј, H-5Ј and H-7Ј, and H-6Ј and H-8Ј. Therefore, the relative stereochemistry of RK-95113 was unambiguously determined as shown in Fig. 1a .
We tested the effects of RK-95113 on the growth of human umbilical vein endothlial cells (HUVECs) and normal human fibroblast WI-38 cells in a proliferation assay. The IC 50 values in the HUVECs of RK-95113, RK-805, fumagillin, and TNP-470 were 0.1, 0.03, 0.5, and 0.06 ng/ml, respectively, whereas they did not exhibit remarkable inhibitory activity in WI-38 cells even at 100 ng/ml, indicating that all these compounds exhibited preferential inhibitory activities in HUVECs (Fig. 2a) .
Next we performed the cell migration assay. VEGF significantly induced cell migration, where as 10 m M of SU5614, an inhibitor of VEGF receptor tyrosine kinase, inhibited the VEGF-induced cell migration (Fig. 2b) [15] . RK-95113 also inhibited cell migration induced by VEGF in a dose-dependent manner without showing significant cell toxicity; this result was estimated by trypan blue dye exclusion assay [10] . The ED 50 value of RK-95113 was ca. 10 ng/ml, as shown in Fig. 2b . Fumagillin exhibited almost the same inhibitory activity in this assay. These results suggested that RK-95113 blocked the function of endothelial cell migration activated by VEGF.
RK-95113 belongs to the fumagillin family including FR-111142 [16] and Sch528647 [17] . At the molecular level, one of the direct targets for fumagillin and its analogues, including RK-805 and ovalicin, has been suspended in Humedia-EG2 medium (Kurabo, Osaka, Japan) with various concentrations of test compounds were added to the upper compartment of a Chemotaxicell chamber (Kurabo) and incubated with HuMedia-EG2 medium containing 12.5 ng/ml of VEGF in the lower compartment for 18 hours at 37°C in a 5% CO 2 atmosphere. The filter was fixed with MeOH and stained with Wright solution. The cells on the upper surface of the filter were removed by wiping with cotton swabs. Cells that migrated through the filter to the areas of the lower surface were counted manually under a microscope at a magnification of ϫ100. Values are meansϮS.D. for triplicate samples.
identified as methionine aminopeptidase-2 (MetAP2), a dimetalloprotease catalyzing the removal of N-terminal methionine in newly formed polypeptide chains [10, 18ϳ20] . In particular, the spiro-epoxide moiety plays a crucial role by creating a covalent bond with a histidine residue (His231) of the active site in human MetAP2. The X-ray crystal structure of fumagillin with human MetAP2 also reveals that a water molecule forms hydrogen bonds with the oxygens of the methoxy group and the epoxide of the alkyl side chain in fumagillin, which plays a role in stabilizing His231 [21] . RK-95113 has a common moiety with fumagillin and its analogue for the above binding with human MetAP2, while the alkenyl side chain, including an octa-2,4,6-trienoic acid ester of RK-95113, is different from the others, especially regarding in the hydrophobicity and polarity. This suggests that RK-95113 may directly inhibit MetAP2 and may have different rates of cellular uptake and metabolism in intact cells. Meanwhile, it is not fully established why endothelial cell growth requires MetAP2, although the ability of fumagillin and its analogues to inhibit endothelial cell growth is related to their ability to inhibit MetAP2 activity in a p53-dependent manner [22, 23] . Moreover, very recently we found that fumagillin and TNP-470 suppress human immunodeficiency virus I (HIV-1) infection of macrophages though the inhibition of HIV-1 viral protein R (VPR) activity, independently from the MetAP2 pathway [24] . Therefore, further comprehensive chemical and biological studies of fumagillin and its analogues, including RK-95113, might shed light on these pivotal events in relation to chemotherapy for angiogenesis-related diseases as well as for HIV-1.
